HomeApproved Therapies

Vamorolone (Agamree) Approved in Scotland

Vamorolone (Agamree) Approved in Scotland
|
Less than 1 min read
|
Updated:

The Scottish Medicines Consortium (SMC) approved the Agamree (Vamorolone) for use by NHS Scotland.

The medication vamorolone, also marketed under the brand name Agamree, has been approved by the Scottish Medicines Consortium (SMC) as a therapy option for Duchenne muscular dystrophy in patients four years of age and older in Scotland as of today, Monday, January 13 2025.

Read More: What is Agamree (vamorolone)? What is Agamree Used For?

- Follow Us -
DMDWarrioR Instagram
SourceMuscular Dystrophy UK
Author: Can Ekinci
Add DMDWarrior as a preferred Google source to see more of our trusted coverage.

Disclaimer: This article is for informational purposes only and does not provide medical advice. Patients and families should discuss treatment options and clinical trials with their healthcare professionals.

DMDWarrior Clinical Trials Hub now available in 10 languages, providing AI-assisted Duchenne clinical trial information worldwide.

Trending on DMDWarrioR- Duchenne News

Load more

Related Articles

Load more